DMCC Speciality Chemicals Schedules Q4 & FY26 Earnings Conference Call for May 19, 2026

1 min read     Updated on 14 May 2026, 08:57 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

DMCC Speciality Chemicals Limited has announced a Q4 & FY26 Earnings Conference Call on May 19, 2026 at 12:00 PM IST, filed under SEBI Regulation 30(6). Senior management including Managing Director and CEO Bimal Goculdas, CFO Sunil Kumar Goyal, and Company Secretary Pallavi Pednekar will participate. Investors can register via DiamondPass™ or dial in at +91 22 6280 1341 or +91 22 7115 8242.

powered bylight_fuzz_icon
40219051

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals Limited (formerly known as The Dharamsi Morarji Chemical Company Limited) has announced an Earnings Conference Call to discuss its Q4 & FY26 financial performance with investors and analysts. The intimation was filed pursuant to Regulation 30(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015. The call is scheduled for Tuesday, May 19, 2026 at 12:00 PM (IST).

Conference Call Details

The following key details have been disclosed regarding the earnings call:

Parameter: Details
Event: Q4 & FY26 Earnings Conference Call
Date: Tuesday, May 19, 2026
Time: 12:00 PM (IST)
Dial-in Number 1: +91 22 6280 1341
Dial-in Number 2: +91 22 7115 8242

Management Participants

The following senior management representatives are scheduled to participate in the conference call:

Name: Designation
Mr. Bimal Goculdas Managing Director and CEO
Mr. Dilip Gokhale Sr. Executive Vice-President
Mr. Sunil Kumar Goyal Chief Finance Officer
Ms. Pallavi Pednekar Company Secretary and Compliance Officer

Investor Contact Information

For further information regarding the conference call, stakeholders may reach out through the following contacts:

The intimation was signed by Pallavi Pednekar, Company Secretary & Compliance Officer (ICSI Membership No. ACS 33498), on May 13, 2026. Investors and analysts may register for the call using the DiamondPass™ platform to avoid wait times.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.87%+0.34%+16.66%+10.27%+25.28%+2.45%

How has DMCC Speciality Chemicals' revenue and margin trajectory evolved through FY26, and what guidance might management provide for FY27 amid volatile specialty chemicals demand?

Following the company's rebranding from Dharamsi Morarji Chemical to DMCC Speciality Chemicals, what strategic shifts in product mix or target markets are expected to drive future growth?

How is DMCC Speciality Chemicals positioned to capitalize on the China+1 sourcing trend in specialty chemicals, and what capacity expansion plans might be disclosed during the earnings call?

DMCC Speciality Chemicals
View Company Insights
View All News
like15
dislike

DMCC Speciality Chemicals Board Meeting Scheduled for May 15, 2026 to Consider Q4FY26 Results and Dividend

1 min read     Updated on 07 May 2026, 11:26 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

DMCC Speciality Chemicals Limited has scheduled a board meeting for May 15, 2026, to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also deliberate on a recommendation of final dividend, if any, for FY26, subject to shareholder approval at the 105th Annual General Meeting. The trading window for dealing in the company's securities will remain closed until May 17, 2026, and will reopen on May 18, 2026. The intimation was filed on May 07, 2026, in compliance with Regulation 29 of the SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
39678966

*this image is generated using AI for illustrative purposes only.

DMCC Speciality Chemicals Limited (formerly known as The Dharamsi Morarji Chemical Company Ltd) has notified the stock exchanges of an upcoming board meeting, scheduled for Friday, May 15, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 07, 2026, by Company Secretary & Compliance Officer Pallavi Pednekar.

Key Agenda Items

The board meeting has been convened to consider and approve the following matters, as outlined in the regulatory filing:

Agenda Item: Details
Financial Results: Audited Standalone & Consolidated results for the Quarter and Year ended March 31, 2026
Dividend Recommendation: Final Dividend, if any, for the year ended March 31, 2026, subject to shareholder approval at the 105th Annual General Meeting

Trading Window Closure

In accordance with the company's letter dated March 26, 2026, and pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as well as the company's internal code of conduct for prevention of insider trading, the trading window for dealing in the securities of DMCC Speciality Chemicals will remain closed until 48 hours after the outcome of the board meeting.

The key trading window dates are as follows:

Event: Date
Board Meeting Date: May 15, 2026
Trading Window Closed Until: May 17, 2026
Trading Window Reopens: May 18, 2026

Regulatory Compliance

The intimation has been submitted to both the National Stock Exchange of India Ltd. and BSE Limited, fulfilling the company's disclosure obligations under applicable SEBI regulations. The filing was signed by Pallavi Pednekar, Company Secretary & Compliance Officer (Membership No: A33498), on May 07, 2026.

Historical Stock Returns for DMCC Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.87%+0.34%+16.66%+10.27%+25.28%+2.45%

How might DMCC Speciality Chemicals' FY2026 financial results compare to the previous year, given the company's recent rebranding and strategic shifts under its new name?

What factors could influence the board's decision on declaring a final dividend for FY2026, and how does the company's dividend history align with shareholder expectations?

How could the outcome of the 105th Annual General Meeting shape DMCC Speciality Chemicals' capital allocation strategy and future growth investments?

DMCC Speciality Chemicals
View Company Insights
View All News
like17
dislike

More News on DMCC Speciality Chemicals

1 Year Returns:+25.28%